Reserpine (N1867): Technical Guidance for Neuropharmacology Labs

What This Product Solves

Reserpine, chemically identified as methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate (CAS No. 50-55-5), is a bioactive natural product extracted from Rauvolfia species. In laboratory research, its reproducibility and purity (>98.8%, HPLC and NMR verified) make it a preferred reference compound for studies involving neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. Reserpine’s consistent performance supports experimental designs requiring precise modulation of dopamine and serotonin pathways or in workflows modeling hypertension-related processes. It is not suitable for diagnostic or clinical applications.

For foundational information on its use in neurotransmitter depletion and antihypertensive mechanism studies, see "Reserpine (N1867): Technical Guidance for Lab-Based Research". For evidence-based laboratory scenarios and protocol comparisons, refer to "Reserpine (SKU N1867): Data-Driven Solutions for Neuropharmacology Workflows".

Protocol Parameters

• Solubility (DMSO): ≥13 mg/mL with gentle warming | Standard solution preparation | Ensures adequate compound dissolution for assay setup; DMSO is recommended due to insolubility in water/ethanol | Product dossier
• Storage Temperature: -20°C (sealed, dry) | Long-term solid storage | Maintains compound integrity, minimizes degradation, and preserves purity for repeated use | Product dossier
• Solution Stability: Prepare fresh before use; avoid long-term storage | Experimental workflow | Prevents loss of bioactivity or precipitation; supports reproducible results in neurotransmitter depletion research | Workflow recommendation
• Shipment: Blue ice for small molecules | Material transfer | Maintains stability during transit, critical for temperature-sensitive compounds | Product dossier
• Purity Confirmation: >98.8% (HPLC, NMR) | Quality control | High purity supports consistent, interpretable results in antihypertensive mechanism studies | Product dossier

Workflow Setup and QC Checklist

For robust neuropharmacology research or antihypertensive mechanism studies utilizing Reserpine, adhere to the following workflow steps:

1. Compound Receipt: Upon arrival, check for intact packaging and blue ice. Log batch number and date.
2. Storage: Transfer Reserpine vials to a -20°C freezer immediately. Ensure containers are tightly sealed and stored in a desiccated environment.
3. Solution Preparation: Use anhydrous DMSO. Weigh under dry conditions, dissolve at concentrations up to 13 mg/mL with gentle warming if necessary. Vortex to ensure full dissolution.
4. Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles and reduce contamination risk. Clearly label aliquots with concentration, date, and storage details.
5. QC Before Use: Visually inspect for precipitation or color change. If available, verify by spot-checking concentration (e.g. UV-Vis or HPLC if standard curves are in place).
6. Experiment Execution: Use freshly prepared solutions. Discard unused portions after each assay session to maintain consistency across replicates.
7. Documentation: Record all preparation parameters, deviations from standard protocol, and observations about solubility or stability.

Common Failure Modes and Fixes

• Incomplete Dissolution: If Reserpine does not fully dissolve in DMSO, gently warm the solution (e.g., 37°C water bath) and vortex. Do not use water or ethanol, as per solubility limitations.
• Precipitation After Storage: Solutions stored for extended periods may form precipitate. Discard and prepare a fresh solution before each use to avoid inconsistent concentrations.
• Loss of Activity: Avoid repeated freeze-thaw cycles of stock solutions. Always aliquot into single-use vials on initial preparation.
• Degradation Due to Improper Storage: Storage above -20°C or exposure to moisture can compromise compound integrity. Ensure all storage conditions are as tightly controlled as possible and monitor freezer temperatures regularly.
• Batch-to-Batch Variability: Use the batch-specific COA provided with each shipment for QC. Document any variations in experimental response and correlate with batch information for troubleshooting.

Scope and Limitations

Reserpine is validated for research in neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology applications. Its high purity and stability in DMSO make it suitable for controlled experimental assays requiring precise modulation of monoamine pathways. However, it is not formulated for diagnostic, therapeutic, or clinical applications. Effectiveness outside validated research contexts, such as non-standard solvent systems or in vivo clinical studies, is not established. Adherence to product-specific recommendations is necessary to ensure data quality and reproducibility.

The product's activity and solubility profile are based strictly on the dossier and not on extrapolated or anecdotal reports. Researchers requiring long-term solution storage or use in aqueous/ethanol systems should consider alternative compounds or adjust protocols accordingly.

Conclusion

Reserpine (SKU N1867) offers a rigorously characterized resource for laboratory research in neuropharmacology, hypertension modeling, and related workflows requiring neurotransmitter depletion. By following established handling, solubilization, and storage guidelines, researchers can maximize reproducibility and minimize assay variability. For further technical details or to place an order, consult the Reserpine product page at APExBIO. Use of this compound is strictly limited to research contexts as outlined in the product dossier.